BJDX (BJDX) Stock Price & Analysis
BJDX (BJDX) fell 1.94% to USD 0.83 as of September 8, 2026 at 06:56 UTC, according to Nexqual real-time market data.
BJDX last closed at USD 0.83; the session ranged USD 0.82–0.85 on volume of 92,004 shares. Market capitalization is —, with a 52-week range of USD 0.82–16.68 (NCM). Source: Nexqual, September 8, 2026 at 06:56 UTC.
Key Statistics (as of September 8, 2026 at 06:56 UTC)
| Price | USD 0.83 |
|---|---|
| Change | ▼ 1.94% (down) |
| Previous Close | USD 0.83 |
| Open | USD 0.83 |
| Day Range | USD 0.82 – 0.85 |
| 52-Week Range | USD 0.82 – 16.68 |
| Volume | 92,004 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (BJDX)
Nexqual's technical model rates BJDX "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:56 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 34.89 (neutral) |
| vs SMA50 | Below (USD 1.12) |
| MACD | -0.12 (negative) |
From BJDX's Latest SEC 10-K Filing (filed 2026-03-06)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBLG | Bone Biologics Corp | USD 0.57 | ▲ 3.27% |
| DRMA | Dermata Therapeutics, Inc. | USD 1.21 | ▼ 5.47% |
| PRFX | PRF Technologies Ltd. | USD 0.97 | ▼ 0.72% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.46 | ▲ 2.93% |
| KTTA | Pasithea Therapeutics Corp. | USD 0.58 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:56 UTC. This page is informational and not investment advice.